[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO821084L - PROCEDURE FOR PREPARING GALENIC PREPARATION WITH CONSTANT ACTUAL RELEASE - Google Patents

PROCEDURE FOR PREPARING GALENIC PREPARATION WITH CONSTANT ACTUAL RELEASE

Info

Publication number
NO821084L
NO821084L NO821084A NO821084A NO821084L NO 821084 L NO821084 L NO 821084L NO 821084 A NO821084 A NO 821084A NO 821084 A NO821084 A NO 821084A NO 821084 L NO821084 L NO 821084L
Authority
NO
Norway
Prior art keywords
active compound
procedure
actual release
galenic preparation
constant actual
Prior art date
Application number
NO821084A
Other languages
Norwegian (no)
Other versions
NO157204B (en
NO157204C (en
Inventor
Heinz Einig
Volker Buehler
Winfried Koch
Joachim Arthur Schwarz
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6129505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO821084(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO821084L publication Critical patent/NO821084L/en
Publication of NO157204B publication Critical patent/NO157204B/en
Publication of NO157204C publication Critical patent/NO157204C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

1. A pharmaceutical composition which contains a calcium-antagonistic active compound, with or without additional active compounds, is intended for oral administration to produce a sustained action for continuous therapy and contains only the sustaining dose of active compound, bound to pharmaceutical auxiliaries, wherein the calcium-antagonistic active compound is Gallopamil or Verapamil and wherein, at the sustaining dose, the ratio of the constituents with rapid release of active compound to those with sustained release of active compound is from 1 : 0.6 to 1 : 6.
NO821084A 1981-04-07 1982-03-31 PROCEDURE FOR THE PREPARATION OF GALENIC PREPARATION WITH CONSTANT EFFECTIVENESS. NO157204C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813113901 DE3113901A1 (en) 1981-04-07 1981-04-07 ACTIVE SUBSTANCE PREPARATION FOR ORAL APPLICATION

Publications (3)

Publication Number Publication Date
NO821084L true NO821084L (en) 1982-10-08
NO157204B NO157204B (en) 1987-11-02
NO157204C NO157204C (en) 1988-02-10

Family

ID=6129505

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821084A NO157204C (en) 1981-04-07 1982-03-31 PROCEDURE FOR THE PREPARATION OF GALENIC PREPARATION WITH CONSTANT EFFECTIVENESS.

Country Status (17)

Country Link
EP (1) EP0063266B1 (en)
JP (1) JPS57175113A (en)
AT (1) ATE14076T1 (en)
AU (1) AU555093B2 (en)
CA (1) CA1184497A (en)
DE (2) DE3113901A1 (en)
DK (1) DK157482A (en)
ES (1) ES511208A0 (en)
FI (1) FI821253L (en)
GR (1) GR74770B (en)
HU (1) HU186855B (en)
IE (1) IE52985B1 (en)
IL (1) IL65328A (en)
NO (1) NO157204C (en)
NZ (1) NZ200244A (en)
PT (1) PT74705B (en)
ZA (1) ZA822327B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
LU86077A1 (en) * 1985-09-18 1987-04-02 Pharlyse Sa NEW GALENIC FORMS OF VERAPAMIL, THEIR MANUFACTURE AND THE MEDICINAL PRODUCTS CONTAINING THESE NEW GALENIC FORMS
LU86099A1 (en) * 1985-09-30 1987-04-02 Pharlyse EXTENDED RELEASE GALENIC FORMS OF VERAPAMIL, THEIR MANUFACTURE AND THE MEDICINAL PRODUCTS CONTAINING THEM
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4981871A (en) * 1987-05-15 1991-01-01 Abelson Mark B Treatment of ocular hypertension with class I calcium channel blocking agents
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3809764A1 (en) * 1988-03-23 1989-10-05 Knoll Ag MIXTURE OF ALGINATES AND POLYACRYLATES AND THEIR USE
US5230901A (en) * 1988-03-23 1993-07-27 Knoll Ag Sustained release tablet of a mixture of alginates and polyacrylates
WO1990000391A1 (en) * 1988-07-13 1990-01-25 Knoll Aktiengesellschaft Depot-form of an alginate-based drug
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
DE3932378A1 (en) * 1989-09-28 1991-04-11 Knoll Ag SOLID MEDICAL FORM WITH A HIGH VERAPAMIL CONTENT
IT1264696B1 (en) * 1993-07-09 1996-10-04 Applied Pharma Res PHARMACEUTICAL FORMS INTENDED FOR ORAL ADMINISTRATION ABLE TO RELEASE ACTIVE SUBSTANCES AT A CONTROLLED AND DIFFERENTIATED SPEED
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (en) * 1961-04-01 1963-09-26 Knoll Ag Process for the preparation of basic substituted phenylacetonitriles
DE1467781A1 (en) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Process for the production of coated tablets with extended release of active ingredients

Also Published As

Publication number Publication date
DE3113901A1 (en) 1982-10-28
AU8238482A (en) 1982-10-14
ES8307496A1 (en) 1983-08-16
EP0063266A2 (en) 1982-10-27
ES511208A0 (en) 1983-08-16
IE52985B1 (en) 1988-04-27
NO157204B (en) 1987-11-02
ZA822327B (en) 1983-03-30
IL65328A0 (en) 1982-05-31
CA1184497A (en) 1985-03-26
NO157204C (en) 1988-02-10
PT74705B (en) 1983-11-14
ATE14076T1 (en) 1985-07-15
JPS57175113A (en) 1982-10-28
GR74770B (en) 1984-07-12
HU186855B (en) 1985-10-28
IE820812L (en) 1982-10-07
FI821253L (en) 1982-10-08
NZ200244A (en) 1984-08-24
PT74705A (en) 1982-05-01
EP0063266B1 (en) 1985-07-03
EP0063266A3 (en) 1983-05-04
AU555093B2 (en) 1986-09-11
DK157482A (en) 1982-10-08
DE3264519D1 (en) 1985-08-08
IL65328A (en) 1985-06-30
FI821253A0 (en) 1982-04-07

Similar Documents

Publication Publication Date Title
NO821084L (en) PROCEDURE FOR PREPARING GALENIC PREPARATION WITH CONSTANT ACTUAL RELEASE
FI873225A (en) Process for the preparation of an oral, galenic naproxen composition from which the active substance is released in a programmed manner
NO171365C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLD DERIVATIVES
ATE154354T1 (en) AZABICYCLIC COMPOUNDS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THERAPEUTIC USE
DK0438249T3 (en) Naproxen formulation with controlled absorption for once daily administration
ATE86480T1 (en) CONTROLLED RELEASE GALENIC FORMULATIONS.
DE59410151D1 (en) Oral dosage forms containing flupirtine with controlled release of active ingredients
ES2051834T3 (en) THE USE OF TETRAHYDROBENZENE (C, D) INDOL-6 CARBOXAMIDES FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF ANXIETY.
KR830002510A (en) Composition consisting of biologically active compound and hydroxyalkyl starch
HK134494A (en) Substituted release azelastine containing medicaments
DE3474774D1 (en) Therapeutic compositions for oral use containing stable s-adenosy1-l-methionine salts
KR890004705A (en) Antiviral agents
JPS5626819A (en) Preventive for hypoimmunity
KR910018026A (en) Drugs for treating urination disorders containing α-phenyl-αpyridylalkanoic acid derivatives
SE8304818L (en) MEDICINE WITH ANTICULAR, SPASMOLYTIC AND LOCAL ANESTIC EFFECTS
KR890002058A (en) 2,4,6-tris-3-tert-butylamino-1, -3, -5-triazine for the prevention and treatment of epilepsy and anxiety
TH3319EX (en) Methods for preparation N- (2-Pyrityl) -2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamide -1,1 an Oxide